Pulmonary alveolar proteinosis (PAP) is a rare phenotype of IARS1 deficiency ... They both experienced respiratory distress and oxygen dependence since infancy. Their chest CT scans revealed diffuse ...

The progression of CAR-Ms therapies into clinical trials, as evidenced by the FDA’s approval of candidates like CT-0508, marks a critical milestone ... Resolve the pathology of pulmonary alveolar ...

LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...

Before you leave... As a nonprofit newsroom, we believe the healthiest way to sustain and grow CT Mirror is through the support of people who use and value it — loyal, curious readers like you.

Lipoid proteinosis (LP), also known as Urbach-Wiethe disease, is a rare genetic disorder characterized by the deposition of an amorphous hyaline material in various tissues, including the skin and ...

Depth of office market dive in CT city still being tested. See where the trouble spots are. The pandemic showed that offices still remained essential to the economic ecosystem that supports ...

From scenic drives through the countryside and sunbathing on the beach to fresh seafood and towns rich with history, the Constitution State has much to offer travelers. The word "Connecticut ...

No extract is available for articles shorter than 400 words.

Background: Idiopathic pulmonary alveolar proteinosis (PAP) has recently been recognised as a disease of impaired alveolar macrophage function caused by neutralising anti-granulocyte-macrophage colony ...

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the publication of a manuscript detailing long-term outcomes for molgramostim inhalation solution in patients with autoimmune pulmonary ...